In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of cyclic nucleotide gated channel beta 1, encoded by CNGB1, in cancer of the vulva. CNGB1 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of doublecortin-like kinase 1, encoded by DCLK1, in cancer of the vulva. DCLK1 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of histone cluster 1, H2bh, encoded by HIST1H2BH, in cancer of the vulva. HIST1H2BH may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of NUAK family kinase 1, encoded by NUAK1, in cancer of the vulva. NUAK1 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of zinc finger protein 423, encoded by ZNF423, in cancer of the vulva. ZNF423 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of C-X-C motif chemokine ligand 12, encoded by CXCL12, in cancer of the vulva. CXCL12 may be of pertinence to understanding transformation and disease progression in vulvar cancer (3).
Differential expression of CNGB1 in cancer of the vulva.
